152 related articles for article (PubMed ID: 16475720)
1. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
Gyémánt N; Tanaka M; Molnár P; Deli J; Mándoky L; Molnár J
Anticancer Res; 2006; 26(1A):367-74. PubMed ID: 16475720
[TBL] [Abstract][Full Text] [Related]
2. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
3. Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids.
Molnár J; Gyémánt N; Mucsi I; Molnár A; Szabó M; Körtvélyesi T; Varga A; Molnár P; Tóth G
In Vivo; 2004; 18(2):237-44. PubMed ID: 15113052
[TBL] [Abstract][Full Text] [Related]
4. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells.
Gyémánt N; Tanaka M; Antus S; Hohmann J; Csuka O; Mándoky L; Molnár J
In Vivo; 2005; 19(2):367-74. PubMed ID: 15796199
[TBL] [Abstract][Full Text] [Related]
5. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
6. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
7. Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP.
Ugocsai K; Varga A; Molnár P; Antus S; Molnár J
In Vivo; 2005; 19(2):433-8. PubMed ID: 15796208
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
Kars MD; Işeri OD; Gunduz U; Molnar J
Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
[TBL] [Abstract][Full Text] [Related]
9. MDR-reversal activity of chalcones.
Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
11. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of P-glycoprotein transport function by N-acylphenothiazines.
Wesolowska O; Molnár J; Motohashi N; Michalak K
Anticancer Res; 2002; 22(5):2863-7. PubMed ID: 12530010
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones.
Ferreira MJ; Gyémánt N; Madureira AM; Molnár J
Anticancer Res; 2005; 25(5):3259-62. PubMed ID: 16101136
[TBL] [Abstract][Full Text] [Related]
14. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
[TBL] [Abstract][Full Text] [Related]
15. Time-lapse live cell imaging and flow analysis of multidrug resistance reversal by verapamil in bladder cancer cell lines.
Featherstone JM; Lwaleed BA; Speers AG; Hayes MC; Birch BR; Cooper AJ
Urology; 2009 Aug; 74(2):378-84. PubMed ID: 19501884
[TBL] [Abstract][Full Text] [Related]
16. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
[TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.
Molnar J; Molnar A; Mucsi I; Pinter O; Nagy B; Varga A; Motohashi N
In Vivo; 2003; 17(2):145-9. PubMed ID: 12792975
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of alkaloids derived from Amaryllidaceae species.
Zupkó I; Réthy B; Hohmann J; Molnár J; Ocsovszki I; Falkay G
In Vivo; 2009; 23(1):41-8. PubMed ID: 19368123
[TBL] [Abstract][Full Text] [Related]
19. Cinnamylidene ketones as potential modulators of multidrug resistance in mouse lymphoma and human colon cancer cell lines.
Engi H; Gyémánt N; Lóránd T; Lévai A; Ocsovszki I; Molnár J
In Vivo; 2006; 20(1):119-24. PubMed ID: 16433039
[TBL] [Abstract][Full Text] [Related]
20. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]